RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
Código da empresaRXST
Nome da EmpresaRxsight Inc
Data de listagemJul 30, 2021
CEODr. Ron M. Kurtz, M.D.
Número de funcionários498
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 30
Endereço100 Columbia Street
CidadeALISO VIEJO
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal92656
Telefone19495217822
Sitehttps://www.rxsight.com/
Código da empresaRXST
Data de listagemJul 30, 2021
CEODr. Ron M. Kurtz, M.D.
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados